Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG

(EUZ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

DGAP-Adhoc: Eckert & Ziegler Receives Technetium Generator Licenses for Brazil

04/12/2021 | 03:14pm EDT
DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company Decision/Miscellaneous 
Eckert & Ziegler Receives Technetium Generator Licenses for Brazil 
12-Apr-2021 / 21:12 CET/CEST 
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a 
service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Sao Paulo, 12 April 2021 - The Brazilian regulator ANVISA has provided Eckert & Ziegler Brasil Comercial Ltda., a fully 
owned subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), with a license to 
import and distribute technetium generators. This is the second license ever given to an organization in Brazil, and 
only the first one for a private company. Technetium generators are a core component for a nuclear imaging procedure 
called SPECT, which is used for the detection of medical abnormalities. In Brazil, the SPECT market has a volume of 
about 100 mm Euro annually. Eckert & Ziegler already services about 500 hospitals and clinics in this country with 
medical devices and radioisotopes, and hopes to start shipping SPECT products in the third quarter of 2021. 
Contact: 
Eckert & Ziegler AG, Karolin Riehle, Investor Relations 
Robert-Rössle-Str. 10, 13125 Berlin, Germany 
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 
=---------------------------------------------------------------------------------------------------------------------- 
Information and Explanation of the Issuer to this News: 
Claudia Goulart, CEO of Eckert & Ziegler Brasil, commented: 'We are very excited that Eckert & Ziegler has now been 
given the opportunity to service the Brazilian nuclear medicine community with SPECT products. It compliments perfectly 
our existing portfolio of radiopharmaceuticals, among them Lu-177 and O-18, and the services we provide for 
international pharmaceutical companies'. 
=---------------------------------------------------------------------------------------------------------------------- 
12-Apr-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and 
Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Eckert & Ziegler Strahlen- und Medizintechnik AG 
              Robert-Rössle-Str.10 
              13125 Berlin 
              Germany 
Phone:        +49 30 941084-138 
Fax:          +49 30 941084-112 
E-mail:       karolin.riehle@ezag.de 
Internet:     www.ezag.de 
ISIN:         DE0005659700 
WKN:          565970 
Indices:      SDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Munich, Stuttgart, Tradegate Exchange 
EQS News ID:  1183796 
 
End of Announcement  DGAP News Service 
=------------ 

1183796 12-Apr-2021 CET/CEST

(END) Dow Jones Newswires

April 12, 2021 15:13 ET (19:13 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL -1.99% 33587.66 Delayed Quote.11.97%
ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG 1.56% 75 Delayed Quote.64.70%
EURO / BRAZILIAN REAL (EUR/BRL) -0.44% 6.3807 Delayed Quote.-0.07%
SDAX -0.34% 15432.91 Delayed Quote.4.89%
SDAX PERFORMANCE INDEX 9:00-20:00 -1.16% 15432.91 Delayed Quote.4.76%
TECDAX 0.75% 3286.99 Delayed Quote.1.54%
TECDAX PERFORMANCE INDEX 9:00-20:00 0.62% 3286.99 Delayed Quote.1.66%
All news about ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
05/11ECKERT & ZIEGLER STRAHLEN- UND MEDIZ : Release according to Article 40, Section ..
EQ
05/10ECKERT & ZIEGLER STRAHLEN- UND MEDIZ : Preliminary announcement of the publicati..
EQ
04/28ECKERT & ZIEGLER STRAHLEN UND MEDIZI : & Ziegler Signs Long-Term Supply Agreemen..
PU
04/28PRESS RELEASE : Eckert & Ziegler Signs Long-Term Supply Agreement with Sirtex Me..
DJ
04/28ECKERT & ZIEGLER STRAHLEN UND MEDIZI : & Ziegler Signs Long-Term Supply Agreemen..
EQ
04/20ECKERT & ZIEGLER STRAHLEN- UND MEDIZ : Release according to Article 40, Section ..
EQ
04/20DGAP-PVR : Eckert & Ziegler Strahlen- und Medizintechnik AG: Release according t..
DJ
04/16ECKERT & ZIEGLER STRAHLEN UND MEDIZI : ​​​​​​..
PU
04/16DGAP-ADHOC : ???????Eckert & Ziegler Acquires Direct Majority Stake in Drug Deve..
DJ
04/16ECKERT & ZIEGLER STRAHLEN UND MEDIZI : ???????Eckert & Ziegler Acquires Direct M..
EQ
More news
Financials
Sales 2021 180 M 217 M 217 M
Net income 2021 27,2 M 32,8 M 32,8 M
Net cash 2021 104 M 126 M 126 M
P/E ratio 2021 57,7x
Yield 2021 0,56%
Capitalization 1 521 M 1 836 M 1 836 M
EV / Sales 2021 7,89x
EV / Sales 2022 6,44x
Nbr of Employees 828
Free-Float 66,3%
Chart ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Duration : Period :
Eckert & Ziegler Strahlen- und Medizintechnik AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 80,00 €
Last Close Price 73,85 €
Spread / Highest target 8,33%
Spread / Average Target 8,33%
Spread / Lowest Target 8,33%
EPS Revisions
Managers and Directors
NameTitle
Andreas Eckert Chairman-Executive Board
Wolfgang Maennig Chairman-Supervisory Board
Helmut Grothe Vice Chairman-Supervisory Board
Albert Rupprecht Member-Supervisory Board
Edgar L÷ffler Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG64.70%1 836
JOHNSON & JOHNSON6.88%444 728
ROCHE HOLDING AG-3.32%285 850
PFIZER, INC.6.90%219 501
ABBVIE INC.7.29%202 921
NOVARTIS AG-5.65%196 492